FEATURED ARTICLES

• How Real-World Data On Site Costs Accelerates Clinical Trial Success

  Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

• eCOA In Oncology Trials: A Tool To Simplify

  Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.

• Why Real-Time eCOA Data Matters More Than Ever

  Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• Managing Drug And Data Requirements In Decentralized Clinical Trials

  Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.

• 5 Essential Steps To Implementing Decentralized Clinical Trials Globally

  Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.

• Sustainable Clinical Trials Through eClinical Innovation

  Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.

• Honoring Patient Altruism: Empowering Trial Participants With Better Technology

  Simplifying participation honors patient altruism, improves engagement, and strengthens the quality of trial data, ultimately advancing medical innovation.

• How Cara Therapeutics Increased Compliance And Reduced Study Team Burden

  Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.

• Managing Risk And Regulation In Clinical Trial Technology

  Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.

• Recent Updates To The Declaration Of Helsinki Affecting Clinical Trials

  The World Medical Association (WMA) has announced a significant, rare update to its cornerstone ethical document, the Declaration of Helsinki, which guides medical research involving human participants.

• Potential Of eClinical Solutions To The Complexity Of Oncology Trials

  How are eClinical technologies—specifically IRT and eCOA— being leveraged to overcome patient recruitment difficulties, high mortality rates, and the intricacies of cancer treatments.

• Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial

  Embrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.

• Navigating eCOA Licensing And Localization In Clinical Trials

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• Navigating The Next Wave Of Innovation In eCOA

  Learn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.